Argitalpenak (86) Miguel Valencia Ustárroz argitalpenak

2024

  1. Cortical activation in REM behavior disorder mimics voluntary movement. An electroencephalography study

    Clinical Neurophysiology, Vol. 166, pp. 191-198

  2. GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model

    Translational Neurodegeneration

  3. Optogenetic inhibition of the limbic corticothalamic circuit does not alter spontaneous oscillatory activity, auditory-evoked oscillations, and deviant detection

    Scientific Reports, Vol. 14, Núm. 1

  4. Pharmacological inhibition of the integrated stress response accelerates disease progression in an amyotrophic lateral sclerosis mouse model

    British Journal of Pharmacology, Vol. 181, Núm. 3, pp. 495-508

2023

  1. Effect of sugammadex on processed EEG parameters in patients undergoing robot-assisted radical prostatectomy

    British Journal of Anaesthesia, Vol. 131, Núm. 3, pp. 523-530

  2. Glutamatergic and GABAergic Receptor Modulation Present Unique Electrophysiological Fingerprints in a Concentration-Dependent and Region-Specific Manner

    eNeuro, Vol. 10, Núm. 4

  3. Multimodal Minimally Invasive Wearable Technology for Epilepsy Monitoring: A Feasibility Study of the Periauricular Area

    IEEE Sensors Journal, Vol. 23, Núm. 21, pp. 26620-26635

  4. Open Hardware Implementation of Real-Time Phase and Amplitude Estimation for Neurophysiologic Signals

    Bioengineering, Vol. 10, Núm. 12

2022

  1. An interactive framework for the detection of ictal and interictal activities: Cross-species and stand-alone implementation

    Computer Methods and Programs in Biomedicine, Vol. 218

  2. GABABR activation partially normalizes acute NMDAR hypofunction oscillatory abnormalities but fails to rescue sensory processing deficits

    Journal of Neurochemistry, Vol. 161, Núm. 5, pp. 417-434

  3. Neurexin1α knockout rats display oscillatory abnormalities and sensory processing deficits back-translating key endophenotypes of psychiatric disorders

    Translational Psychiatry, Vol. 12, Núm. 1

2021

  1. Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation (Scientific Reports, (2019), 9, 1, (14172), 10.1038/s41598-019-50627-w)

    Scientific Reports

  2. Effects of dexmedetomidine on subthalamic local field potentials in Parkinson's disease

    British Journal of Anaesthesia, Vol. 127, Núm. 2, pp. 245-253

  3. Imaging of Stroke in Rodents Using a Clinical Scanner and Inductively Coupled Specially Designed Receiver Coils

    Annals of Biomedical Engineering, Vol. 49, Núm. 2, pp. 746-756

  4. Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 585-602

2020

  1. Abnormal brain gamma oscillations in response to auditory stimulation in Dravet syndrome

    European Journal of Paediatric Neurology, Vol. 24, pp. 134-141

  2. Cholinergic midbrain afferents modulate striatal circuits and shape encoding of action strategies

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Theta-phase closed-loop stimulation induces motor paradoxical responses in the rat model of Parkinson disease

    Brain Stimulation, Vol. 11, Núm. 1, pp. 231-238

2017

  1. A typical antipsychotics normalize low-gamma evoked oscillations in patients with schizophrenia

    Psychiatry Research, Vol. 247, pp. 214-221